ProPhase Labs, Inc. (PRPH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 20M 40M 60M Q2 '21: 9.1M Q3 '21: 9.5M Q4 '21: 45.2M Q1 '22: 47.5M Q2 '22: 29.1M Q3 '22: 24.2M Q4 '22: 21.8M Q1 '23: 19.3M Q2 '23: 13.2M Q3 '23: 8.4M Q1 '24: 2.4M Q2 '24: 1.5M Q3 '24: 1.4M Q4 '24: 1.5M Q1 '25: 1.4M Q2 '25: 1.2M Q3 '25: 883K Q4 '25: 784K Q1 '26: 1.2M Q2 '26: 1M Q3 '21 Q2 '22 Q1 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

-10M 0 10M 20M 30M Q2 '21: 4.5M Q3 '21: 4M Q4 '21: 24.6M Q1 '22: 28.7M Q2 '22: 18.7M Q3 '22: 12M Q4 '22: 11.3M Q1 '23: 10.5M Q2 '23: 6.4M Q3 '23: 2.3M Q1 '24: -60K Q2 '24: -155K Q3 '24: 215K Q4 '24: -150K Q1 '25: 526K Q2 '25: 734K Q3 '25: -123K Q4 '25: 247K Q1 '26: 295K Q2 '26: 226K Q3 '21 Q2 '22 Q1 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-18M -12M -6M 0 6M 12M 18M Q2 '21: -1.4M Q3 '21: -3.6M Q4 '21: 13.7M Q1 '22: 16.1M Q2 '22: 10.6M Q3 '22: 2M Q1 '23: 875K Q2 '23: -4.7M Q3 '23: -6.5M Q4 '23: -11M Q1 '24: -7.6M Q2 '24: -7.2M Q3 '24: -6.5M Q4 '24: -17.3M Q1 '25: -3.7M Q2 '25: -3.9M Q3 '25: -4.8M Q4 '25: -5.7M Q1 '26: -2.4M Q2 '26: -2.6M Q3 '21 Q2 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q2 '21: -1.4M Q3 '21: -4M Q4 '21: 10.6M Q1 '22: 12.5M Q2 '22: 7.4M Q3 '22: 968K Q1 '23: 550K Q2 '23: -3.4M Q3 '23: -5.1M Q4 '23: -8.8M Q1 '24: -6.3M Q2 '24: -6.2M Q3 '24: -6.6M Q4 '24: -34.4M Q1 '25: 4M Q2 '25: -4.5M Q3 '25: -6.8M Q4 '25: -7.4M Q1 '26: -5.2M Q2 '26: -3.1M Q3 '21 Q2 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 7M 14M 21M Q2 '21: 4.7M Q3 '21: 5.5M Q4 '21: 20.5M Q1 '22: 18.9M Q2 '22: 10.4M Q3 '22: 12.2M Q4 '22: 10.5M Q1 '23: 8.8M Q2 '23: 6.8M Q3 '23: 6M Q1 '24: 2.4M Q2 '24: 1.7M Q3 '24: 1.2M Q4 '24: 1.6M Q1 '25: 905K Q2 '25: 513K Q3 '25: 1M Q4 '25: 537K Q1 '26: 874K Q2 '26: 785K Q3 '21 Q2 '22 Q1 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-7M 0 7M 14M 21M Q3 '21: -5.5M Q4 '21: -4.6M Q1 '22: 20.3M Q2 '22: 4.8M Q3 '22: 2.6M Q4 '22: 811K Q1 '23: 476K Q2 '23: -7M Q3 '23: -4.7M Q4 '23: -753K Q1 '24: -5.1M Q2 '24: -4.8M Q3 '24: -4M Q4 '24: -3.5M Q1 '25: -3.4M Q2 '25: -247K Q3 '25: -3.5M Q4 '25: -1.2M Q1 '26: -748K Q2 '26: -78K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-14M -7M 0 7M 14M 21M Q1 '21: -11.8M Q2 '21: 4.1M Q3 '21: -5.5M Q4 '21: -4.7M Q1 '22: 19.2M Q2 '22: 4.1M Q3 '22: 2.1M Q4 '22: -785K Q1 '23: -41K Q2 '23: -7.6M Q3 '23: -5.3M Q4 '23: -992K Q1 '24: -6M Q2 '24: -4.8M Q3 '24: -4M Q4 '24: -3.6M Q1 '25: -3.4M Q2 '25: -247K Q3 '25: -3.5M Q4 '25: -1.2M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '19: 11.6K Q1 '20: 11.6M Q2 '20: 11.6K Q1 '21: 18.2K Q2 '21: 15.2K Q3 '21: 15.4K Q1 '22: 18.7K Q2 '22: 19.3K Q3 '22: 20.2M Q1 '23: 18.1M Q2 '23: 16.8M Q3 '23: 17.2M Q1 '24: 17.2M Q2 '24: 18.9M Q3 '24: 19.1M Q1 '25: 3.5M Q2 '25: 4.2M Q3 '25: 41.5M Q1 '26: 12.3M Q2 '26: 14M Q1 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-30.00 -20.00 -10.00 0.00 10.00 20.00 30.00 Q1 '11: -0.24 Q3 '12: 0.13 Q4 '12: 0.29 Q4 '23: -0.98 Q1 '24: -1.37 Q2 '24: -1.50 Q3 '24: -1.55 Q4 '24: -26.70 Q1 '25: -25.21 Q2 '25: -25.96 Q3 '25: -25.77 Q4 '25: -1.66 Q1 '26: -3.21 Q2 '26: -2.35 Q3 '12 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.